Lice Treatment Market Research Report, by type (pediculosis capitis, pediculosis corporis, pediculosis pubis), treatment (OTC products, prescription medications), distribution channel (online platform, hospitals & clinics) – Global Forecast till 2027
ID: MRFR/Pharma/5668-HCR | February 2021 | Region: Global | 90 pages
Market Scenario
The Global Lice Treatment Market is expected to register a CAGR of 6.5% during the forecast period of 2018 to 2023. Lice are parasites that feed on human blood, mostly from the head and pubic areas. The medical condition can be infested to others by close contact with carrier or through pets. In recent years, the prevalence of head lice has increased, resulting in a parallel demand for therapeutics. According to an article published by the Centers for Disease Control and Prevention in 2015, it was estimated that ~6 million to 12 million infestations occur each year within the U.S. Moreover, the article further stated that most of the reported cases were for children who aged 3 to 11 years. Trends in the population composition, suggests that this susceptible population has increased. As per the international database of U.S. Census Bureau, there were ~3,416,831 children who aged 5-9 years within Germany. Thus, such high patient pool is projected to fuel the market.
Conclusively, it is observed that high prevalence of head lice and growing children population majorly drives the market. Moreover, factors such as increasing disposable income and rising healthcare expenditure provides suitable boost for the market growth. Contrary to the illustrated facts, it is mentionable that lack of awareness and low per capita healthcare expenditure in the developing and low-income countries restricts the market growth.
Segmentation
The global lice treatment market is segmented based on type, treatment, end user, and region.
On the basis of type, the market is segmented into pediculosis capitis, pediculosis corporis, and pediculosis pubis. Based on treatment, the market is devised into two, i.e., OTC (over the counter) products and prescription medications. The OTC medication segment is sub-segmented into permethrin, pyrethrin, and others. The prescription segment is sub-segmented into ivermectin, spinosad, malathion, and others. By end user, the market is divided into hospitals & clinics, retail pharmacies, online platform. In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.
Regional Market Summary
Global Lice treatment Market Share (%), by Region, 2017
Sources: Centers for Disease Control and Prevention, U.S. Census Bureau, Kodiak Island Borough School District Annual Reports, Press Release, White Paper, And Company Presentation
The Americas dominated the global market for lice treatment owing to rising children population and presence of major market players within the region. According to the database of the U.S. Census Bureau, it was estimated that there were approximately 20,304,238 children who aged 5-9 years within the region. Moreover, the presence of developed economies and healthcare sector within the region boosts the market growth.
In 2017, it was estimated that Europe stood second in the global lice treatment market. This can be attributed due to the presence of a well-developed healthcare infrastructure, increasing awareness for the condition and presence of developed economies within the region.
Asia Pacific was the fastest growing region for the global lice treatment market in 2017. Factors such high contamination rate, increasing household income and growing penetration of the market players within the region drives the market within the region. A study published in 2014 by the International Journal of Community Based Nursing and Midwifery journal stated that estimated rate of lice contamination was 16.59% in India.
On the other hand, the Middle East and Africa held least share in the global lice treatment market. Presence of poor economies and low per capita income, especially within the African region make the market to lag within the region. Most of the market share within this region is estimated to be held by the Middle East due to increasing government funding in the healthcare, and presence of developed economies like UAE, Kuwait, Dubai, and others.
Key players
Some of the key players in the global lice treatment market are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others
Research Methodology
Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.
- Primary Research
Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
- Secondary Research
Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the lice treatment market. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.
Intended Audience:
- Pharmaceutical companies
- Government and private laboratories
- Research and Development (R&D) companies
- Medical research laboratories
- Market research and consulting service providers
Market Segmentation and Key Market Players:
Global Lice treatment Market, by Type:
- Pediculosis Capitis
- Pediculosis Corporis
- Pediculosis Pubis
Global Lice Treatment Market, by Treatment:
- OTC Products
- Permethrin
- Pyrethrin
- Others
- Prescription Medications
- Ivermectin
- Spinosad
- Malathion
- Others
Global Lice treatment Market, by End-User:
- Hospitals & Clinics
- Retail Pharmacies
- Online Platform
Global Lice Treatment Market, by Key Players:
- AkzoNobel N.V.
- Alliance Pharmaceuticals Ltd.
- Bayer HealthCare
- Dow AgroSciences LLC
- Elanco
- GlaxoSmithKline
- Insight Pharmaceuticals
- Johnson & Johnson
- Omega Pharma
- Pfizer
- Sanofi
- Suven Life Sciences
- Taro Pharmaceuticals
- Topaz Pharmaceuticals Inc.
Frequently Asked Questions (FAQ) :
Global Lice Treatment Market would grow with a CAGR of 6.5% during the forecast period of 2018 to 2023.
Global Lice Treatment Market can be affected by a lack of awareness and low per capita income.
Lice Treatment Market has end users like retail pharmacies, hospitals & clinics, and online platforms.
Americas have a maximum Lice Treatment Market share.
Asia Pacific region would record the fastest growth in the Lice Treatment Market.
Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Lice Treatment Market, by Type
6.1 Introduction
6.2 Pediculosis Capitis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.3 Pediculosis Corporis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
6.4 Pediculosis Corporis
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 7. Global Lice Treatment Market, by Treatment
7.1 Introduction
7.2 OTC Products
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.1 Permethrin
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.2 Pyrethrin
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.2.3 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3 Prescription Medications
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3.1 Ivermectin
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3.2 Spinosad
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3.3 Malathion
Malathion Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
7.3.4 Others
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 8. Global Lice Treatment Market, by By Distribution channel
8.1 Introduction
8.2 Hospitals & Clinics
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.3 Retail Pharmacies
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
8.4 Online Platform
Market Estimates & Forecast, by Region, 2020–2027
Market Estimates & Forecast, by Country, 2020–2027
Chapter 9. Global Lice Treatment Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.2 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11. Company Profiles
11.1 AkzoNobel N.V.
11.1.1 Company Overview
11.1.2 Product Overview
11.1.3 Financials Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Alliance Pharmaceuticals Ltd.
11.2.1 Company Overview
11.2.2 Product Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Bayer HealthCare
11.3.1 Company Overview
11.3.2 Product Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Dow AgroSciences LLC
11.4.1 Company Overview
11.4.2 Technologys/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Elanco
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 GlaxoSmithKline
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Insight Pharmaceuticals
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Johnson & Johnson
11.8.1 Overview
11.8.2 Product/ Technology Overview
11.8.3 Financials
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Omega Pharma
11.9.1 Overview
11.9.2 Product Overview
11.9.3 Financials
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Pfizer
11.10.1 Overview
11.10.2 Product Overview
11.10.3 Financials
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Sanofi
11.11.1 Overview
11.11.2 Product Overview
11.11.3 Financials
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.12 Suven Life Sciences
11.12.1 Overview
11.12.2 Product Overview
11.12.3 Financials
11.12.4 Key Developments
11.12.5 SWOT Analysis
11.13 Taro Pharmaceuticals
11.13.1 Overview
11.13.2 Product Overview
11.13.3 Financials
11.13.4 Key Developments
11.13.5 SWOT Analysis
11.14 Topaz Pharmaceuticals Inc.
11.14.1 Overview
11.14.2 Product Overview
11.14.3 Financials
11.14.4 Key Developments
11.14.5 SWOT Analysis
11.15 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s Viewpoint
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Predictions for the Lice Treatment Market Industry
Chapter 13. Appendix
LIST OF TABLES
Table 1 Global Lice Treatment Market Synopsis, 2020–2027
Table 2 Global Lice Treatment Market Estimates and Forecast, 2020–2027 (USD Million)
Table 3 Global Lice Treatment Market, by Region, 2020–2027 (USD Million)
Table 4 Global Lice Treatment Market, by Type, 2020–2027 (USD Million)
Table 5 Global Lice Treatment Market, by Treatment, 2020–2027 (USD Million)
Table 6 Global Lice Treatment Market, by Distribution channel, 2020–2027 (USD Million)
Table 7 North America: Lice Treatment Market , by Type, 2020–2027 (USD Million)
Table 8 North America: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 9 North America: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
Table 10 US: Lice Treatment Market , by Type, 2020–2027 (USD Million)
Table 11 US: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 12 US: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
Table 13 Canada: Lice Treatment Market ,by Type, 2020–2027 (USD Million)
Table 14 Canada: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 15 Canada: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
Table 16 South America: Lice Treatment Market , by Type, 2020–2027 (USD Million)
Table 17 South America: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 18 South America: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
Table 19 Europe: Lice Treatment Market , by Type, 2020–2027 (USD Million)
Table 20 Europe: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 21 Europe: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
Table 22 Western Europe: Lice Treatment Market , by Type, 2020–2027 (USD Million)
Table 23 Western Europe: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 24 Western Europe: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
Table 25 Eastern Europe: Lice Treatment Market , by Type, 2020–2027 (USD Million)
Table 26 Eastern Europe: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 27 Eastern Europe: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
Table 28 Asia-Pacific: Lice Treatment Market , by Type, 2020–2027 (USD Million)
Table 29 Asia-Pacific: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 30 Asia-Pacific: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
Table 31 Middle East & Africa: Lice Treatment Market , by Type, 2020–2027 (USD Million)
Table 32 Middle East & Africa: Lice Treatment Market , by Treatment, 2020–2027 (USD Million)
Table 33 Middle East & Africa: Lice Treatment Market , by Distribution channel, 2020–2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Lice Treatment Market
Figure 3 Segmentation Market Dynamics for Global Lice Treatment Market
Figure 4 Global Lice Treatment Market Share, by Type, 2020
Figure 5 Global Lice Treatment Market Share, by Treatment, 2020
Figure 6 Global Lice Treatment Market Share, by Distribution channel, 2020
Figure 7 Global Lice Treatment Market Share, by Region, 2020
Figure 8 North America: Global Lice Treatment Market Share, by Country, 2020
Figure 9 Europe: Global Lice Treatment MarketShare, by Country, 2020
Figure 10 Asia-Pacific: Global Lice Treatment Market Share, by Country, 2020
Figure 11 Middle East & Africa: Global Lice Treatment Market Share, by Region, 2020
Figure 12 Global Lice Treatment Market: Company Share Analysis, 2020 (%)
Figure 13 AkzoNobel N.V.: Key Financials
Figure 14 AkzoNobel N.V.: Segmental Revenue
Figure 15 AkzoNobel N.V.: Geographical Revenue
Figure 16 Alliance Pharmaceuticals Ltd.: Key Financials
Figure 17 Alliance Pharmaceuticals Ltd.: Segmental Revenue
Figure 18 Alliance Pharmaceuticals Ltd.: Geographical Revenue
Figure 19 Bayer HealthCare: Key Financials
Figure 20 Bayer HealthCare: Segmental Revenue
Figure 21 Bayer HealthCare: Geographical Revenue
Figure 22 Dow AgroSciences LLC: Key Financials
Figure 23 Dow AgroSciences LLC: Segmental Revenue
Figure 24 Dow AgroSciences LLC: Geographical Revenue
Figure 25 Elanco: Key Financials
Figure 26 Elanco: Segmental Revenue
Figure 27 Elanco: Geographical Revenue
Figure 28 GlaxoSmithKline: Key Financials
Figure 29 GlaxoSmithKline: Segmental Revenue
Figure 30 GlaxoSmithKline: Geographical Revenue
Figure 31 Insight Pharmaceuticals: Key Financials
Figure 32 Insight Pharmaceuticals: Segmental Revenue
Figure 33 Insight Pharmaceuticals: Geographical Revenue
Figure 34 Johnson & Johnson: Key Financials
Figure 35 Johnson & Johnson: Segmental Revenue
Figure 36 Johnson & Johnson: Geographical Revenue
Figure 37 Omega Pharma: Key Financials
Figure 38 Omega Pharma: Segmental Revenue
Figure 39 Omega Pharma: Geographical Revenue
Figure 40 Pfizer: Key Financials
Figure 41 Pfizer: Segmental Revenue
Figure 42 Pfizer: Geographical Revenue
Figure 43 Sanofi: Key Financials
Figure 44 Sanofi: Segmental Revenue
Figure 45 Sanofi: Geographical Revenue